Leadership Overview
Catalent has 6 executives leading key functions including marketing, finance, human resources, revenue, and operations.
Driven by a commitment to patient well-being, Catalent optimizes product development and full life-cycle supply for pharmaceutical, biotech, and consumer health partners globally, solidifying its position as a preferred Contract Development and Manufacturing Organization.
Driven by a commitment to patient well-being, Catalent optimizes product development and full life-cycle supply for pharmaceutical, biotech, and consumer health partners globally, solidifying its position as a preferred Contract Development and Manufacturing Organization.
Leadership Roles at Catalent
Matti Masanovich - Senior VP & Chief Financial Officer
Matti Masanovich, the Senior VP & Chief Financial Officer at Catalent, manages the company's financial health and strategic fiscal planning. Directing all financial operations, including accounting, treasury, and investor relations, the Chief Financial Officer ensures robust financial controls and drives profitable growth across Catalent's global operations. This executive role is critical in supporting Catalent's position as a leading Contract Development and Manufacturing Organization (CDMO), facilitating investments in advanced development sciences and multi-modality manufacturing capabilities. Matti Masanovich oversees the financial aspects of optimizing product development and full life-cycle supply for pharmaceutical, biotech, and consumer health partners. By providing strategic financial guidance, the Chief Financial Officer enables Catalent to effectively serve patients worldwide with innovative medicines and consumer health products. Masanovich's leadership ensures financial stability and supports the company's expansion into new therapeutic areas and markets.
Christopher Hajjar - Vice President, Finance & Biologics, Corporate Financial Planning & Analysis Segment Chief Financial Officer
Christopher Hajjar, the Vice President, Finance & Biologics, Corporate Financial Planning & Analysis Segment Chief Financial Officer at Catalent, spearheads financial planning and analysis for the Biologics segment. This critical role involves detailed financial forecasting, budgeting, and performance analysis, directly supporting Catalent's extensive capabilities in developing and manufacturing complex biologic therapies. Hajjar's oversight ensures financial discipline and strategic resource allocation for Catalent's operations, which are vital for optimizing product development and full life-cycle supply chains. The Segment Chief Financial Officer works closely with leadership to drive financial strategies that enhance Catalent's standing as a premier Contract Development and Manufacturing Organization (CDMO). By providing granular financial insights, Christopher Hajjar contributes to the company's ability to bring innovative medicines and consumer health products to patients globally, reinforcing Catalent's commitment to excellence in pharmaceutical manufacturing.
Aris Gennadios - Group President, Pharma & Consumer Health
Aris Gennadios, the Group President, Pharma & Consumer Health at Catalent, leads strategic operations and business development for the pharmaceutical and consumer health divisions. Gennadios directs the execution of Catalent's comprehensive service offerings, encompassing development sciences, delivery technologies, and multi-modality manufacturing to optimize product development and full life-cycle supply. This leadership position is pivotal in solidifying Catalent's status as a preferred Contract Development and Manufacturing Organization (CDMO) for a diverse range of partners. Aris Gennadios oversees initiatives aimed at advancing the delivery of personalized medicines, blockbuster drugs, and consumer health brand extensions to patients worldwide. The Group President's focus on operational excellence and market expansion ensures Catalent consistently meets the complex demands of the global healthcare industry, driving innovation and ensuring reliable access to essential therapies and products.
Trish Hunt - Group VP & Chief Marketing Officer
Trish Hunt, the Group VP & Chief Marketing Officer at Catalent, directs global marketing strategies to enhance brand visibility and market penetration. Overseeing all promotional activities and market research initiatives, the Chief Marketing Officer ensures alignment with Catalent's mission to optimize product development and supply chains for pharma, biotech, and consumer health partners. This leadership position involves crafting compelling narratives around Catalent's deep-scale expertise in development sciences, delivery technologies, and multi-modality manufacturing. By driving integrated marketing campaigns, Trish Hunt supports the company's role as a preferred Contract Development and Manufacturing Organization (CDMO) for personalized medicines and blockbuster drugs. The Chief Marketing Officer's efforts directly contribute to expanding Catalent's reach and impact in delivering life-changing therapies to patients worldwide.
Lisa Evoli - Senior Vice President and Chief Human Resources Officer
Lisa Evoli, the Senior Vice President and Chief Human Resources Officer at Catalent, directs all human capital strategies to foster a high-performance culture. Overseeing talent acquisition, development, compensation, and employee engagement, the Chief Human Resources Officer ensures Catalent attracts and retains the specialized expertise required for its role as a global leader in pharmaceutical and biotech services. Evoli's leadership is instrumental in supporting the company's mission to optimize product development and full life-cycle supply for partners worldwide. By cultivating a skilled and motivated workforce, Lisa Evoli directly contributes to Catalent's success as a preferred Contract Development and Manufacturing Organization (CDMO). The Chief Human Resources Officer's focus on talent development empowers teams to drive innovation in areas like personalized medicines and advanced manufacturing technologies, ultimately benefiting patients through the reliable delivery of essential health products.
Kassandra Walsh - Senior Account Director & Chief Revenue Officer
Kassandra Walsh, the Senior Account Director & Chief Revenue Officer at Catalent, drives revenue generation and manages key client relationships across the pharmaceutical, biotech, and consumer health sectors. This executive role focuses on maximizing commercial opportunities and ensuring client success throughout product development and life-cycle supply. The Chief Revenue Officer oversees sales strategies and account management, directly contributing to Catalent's growth as a premier Contract Development and Manufacturing Organization (CDMO). Walsh's expertise in client partnerships is crucial for delivering tailored solutions for personalized medicines and blockbuster drugs. By fostering strong collaborations, Kassandra Walsh ensures Catalent effectively meets the evolving needs of its partners, reinforcing the company's commitment to optimizing the delivery of critical health products to patients globally. The Chief Revenue Officer's strategic vision enhances Catalent's market position and drives sustained financial performance.
Explore Leadership Teams in Manufacturing
Bharat Serums And Vaccines Limited (BSV) is one of India's fastest-growing biopharmaceutical companies, dedicated to developing a wide range of biological, biotech, and pharmaceutical products for over 50 years. The company focuses on critical therapeutic areas such as women's health, critical care, and assisted reproductive technology, aiming to improve health and save lives through innovative treatments. BSV is committed to enhancing the quality of life for patients globally, with a strong emphasis on research and development, supported by a team of over 60 scientists. As a part of the Mankind Group, BSV strives to widen accessibility to its products and deliver positive health outcomes.
Company Leadership RA
AS
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a fully integrated global essential medicines company powered by a robust U.S. generics business and a growing branded business as well as deepening portfolios in institutional injectables, biosimilars and select international markets. Together, were rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Today, Amneal is much more than generics. A series of strategic investments over the years has bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. We have also invested substantially in our people through leadership development and employee well-being programs. Together, these advancements have accelerated our ability to deliver innovation, more complex products and broadened portfolios in new categories and geographies. Two decades after our founding, Amneal is better positioned than ever to deliver outcomes that meet important medical needs, make quality medicines more accessible and more affordable, and provide solutions for tomorrows health challenges. We are Amneal and We make healthy possible.
Company Leadership
HK
Crinetics is a pharmaceutical company that develops much-needed therapies for people with endocrine diseases. Were here for patients who are eager to find therapies that provide effective disease control and more simplicity in their lives. We partner with healthcare practitioners to ensure were solving real problems for them. And we build value in the company for investors by filling real market needs. Whatever brought you here, welcome.
Company Leadership NL
NB
IOLCP is a leading manufacturer and supplier of Active Pharmaceutical Ingredients (API) and specialty chemicals, including Ethyl Acetate, which is recognized for its environmentally friendly properties. The company serves pharmaceutical companies globally by providing essential products for key medicines and is committed to sustainable practices and corporate social responsibility. With a strong focus on research and development, IOLCP aims to expand its value-added services in the API market while fostering green chemistry. The organization prides itself on its dedicated workforce and aims to create lasting value for both the planet and communities.
Company Leadership DS
PK
Frequently Asked Questions Regarding Catalent Top Executives and Leadership Team
